2-O-β-D-Glucopyranosyl-(3β,12β)-20-(β-D-glucopyranosyloxy)-12-hydroxydammar-24-en-3-yl-β-D-glucopyranosid
|
|
|
- CAS-Nr.
- 52705-93-8
- Bezeichnung:
- 2-O-β-D-Glucopyranosyl-(3β,12β)-20-(β-D-glucopyranosyloxy)-12-hydroxydammar-24-en-3-yl-β-D-glucopyranosid
- Englisch Name:
- Ginsenoside Rd
- Synonyma:
- Chikusetsusaponin FK7;Gypenoside VIII;ginsenosideR;Panaxoside Rd;GINSENOSIDE RD;GINSENOOSIDERD;Sanchinoside Rd;Rd
Ginsenoside Rd;Ginsenoside Rd-RM;Ginsenoside Rd(AS)
- CBNumber:
- CB1281187
- Summenformel:
- C48H82O18
- Molgewicht:
- 947.15
- MOL-Datei:
- 52705-93-8.mol
|
2-O-β-D-Glucopyranosyl-(3β,12β)-20-(β-D-glucopyranosyloxy)-12-hydroxydammar-24-en-3-yl-β-D-glucopyranosid Eigenschaften
- Schmelzpunkt:
- 204～206℃
- Siedepunkt:
- 1015.6±65.0 °C(Predicted)
- Dichte
- 1.38±0.1 g/cm3(Predicted)
- storage temp.
- Inert atmosphere,2-8°C
- L?slichkeit
- DMSO (Slightly), Methanol (Slightly)
- pka
- 12.85±0.70(Predicted)
- Aggregatzustand
- Solid
- Farbe
- White to Off-White
- Stabilit?t:
- Hygroscopic
- InChIKey
- FBFMBWCLBGQEBU-FIKSETHBNA-N
- LogP
- 3.110 (est)
- CAS Datenbank
- 52705-93-8(CAS DataBase Reference)
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
| Kennzeichnung gef?hrlicher |
Xn |
|
|
| R-S?tze: |
22 |
|
|
| S-S?tze: |
2-45 |
|
|
| WGK Germany |
3 |
|
|
| HS Code |
29389090 |
|
|
| Bildanzeige (GHS) |
|
| Alarmwort |
Warnung |
| Gefahrenhinweise |
| Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
| H302 |
Gesundheitssch?dlich bei Verschlucken. |
Akute Toxizit?t oral |
Kategorie 4 |
Warnung |
![GHS hazard pictograms]() src="/GHS07.jpg" width="20" height="20" /> |
P264, P270, P301+P312, P330, P501 |
|
| Sicherheit |
| P264 |
Nach Gebrauch gründlich waschen. |
| P264 |
Nach Gebrauch gründlich waschen. |
| P270 |
Bei Gebrauch nicht essen, trinken oder rauchen. |
| P301+P312 |
BEI VERSCHLUCKEN: Bei Unwohlsein GIFTINFORMATIONSZENTRUM/Arzt/... (geeignete Stelle für medizinische Notfallversorgung vom Hersteller/Lieferanten anzugeben) anrufen. |
| P501 |
Inhalt/Beh?lter ... (Entsorgungsvorschriften vom Hersteller anzugeben) zuführen. |
|
2-O-β-D-Glucopyranosyl-(3β,12β)-20-(β-D-glucopyranosyloxy)-12-hydroxydammar-24-en-3-yl-β-D-glucopyranosid Chemische Eigenschaften,Einsatz,Produktion Methoden
R-S?tze Betriebsanweisung:
R22:Gesundheitssch?dlich beim Verschlucken.
S-S?tze Betriebsanweisung:
S2:Darf nicht in die H?nde von Kindern gelangen.
S45:Bei Unfall oder Unwohlsein sofort Arzt zuziehen (wenn m?glich, dieses Etikett vorzeigen).
Beschreibung
Ginsenosides are pharmacologically active natural constituents of ginseng and other plants of the genus
Panax. Structurally, they are steroid glycosides derived from the triterpene squalene. Ginsenoside Rd is a protopanaxadiol which is more abundant in some
Panax species (
e.g., P. quinquefolium) than others. This ginsenoside has diverse
in vitro and
in vivo effects, including cardioprotective, neuroprotective, and anti-
inflammatory actions. Notably, ginsenoside Rd is converted to other ginsenosides in response to steaming or heating plant materials, leading to loss of these activities.
Chemische Eigenschaften
White to off-white crystals powder
Verwenden
Ginsenoside RD has been shown to attenuate tau protein phosphorylation via the PI3K/AKT/GSK-3β pathway after forebrain ischemia. This could be used to counter the risk of developing post-stroke dementia.
2-O-β-D-Glucopyranosyl-(3β,12β)-20-(β-D-glucopyranosyloxy)-12-hydroxydammar-24-en-3-yl-β-D-glucopyranosid Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
2-O-β-D-Glucopyranosyl-(3β,12β)-20-(β-D-glucopyranosyloxy)-12-hydroxydammar-24-en-3-yl-β-D-glucopyranosid Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 306)Lieferanten
52705-93-8(2-O-β-D-Glucopyranosyl-(3β,12β)-20-(β-D-glucopyranosyloxy)-12-hydroxydammar-24-en-3-yl-β-D-glucopyranosid)Verwandte Suche:
GINSENOSIDE RE
Ginsenoside Rh2
2-O-(6-Desoxy-α-L-mannopyranosyl)-(3β,6α,12β)-20-(β-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl-β-D-glucopyranosid
(3β,6α,12β)-3,12-Dihydroxydammar-24-en-6,20-diylbis[β-D-glucopyranosid]
Ginsenoside rb1
Ginseng extract
20(R)-Propanaxadiol
TRIBULOSIDE
20-[(6-O-α-L-Arabinofuranosyl-β-D-glucopyranosyl)oxy]-12β-hydroxydammar-24-en-3β-yl-2-O-β-D-glucopyranosyl-β-D-glucopyranosid
20-[(6-O-α-L-Arabinopyranosyl-β-D-glucopyranosyl)oxy]-12β-hydroxydammar-24-en-3β-yl-2-O-β-D-glucopyranosyl-β-D-glucopyranosid
(1S-(1α,2β,5beta))-5-Methyl-(1-isopropyl)cyclohexan-2-ol
3,3,5,5-Tetramethylcyclohexanol
SOY ASAPONIN
2-O-β-D-Glucopyranosyl-(3β,12β)-20-(β-D-glucopyranosyloxy)-12-hydroxydammar-24-en-3-yl-β-D-glucopyranosid
- 2-o-beta-d-glucopyranosyl-(3beta,12beta)-20-(beta-d-glucopyranosyloxy)-12-hydroxydammara-24-en-3-yl-beta-d-glucopyranoside
- GINSENOSIDE RD
- beta-d-glucopyranoside,(3-beta,12-beta)-20-(beta-d-glucopyranosyloxy)-12-hydro
- (3β,12β)-20-(β-D-Glucopyranosyloxy)-12-hydroxydammar-24-en-3-yl 2-O-β-D-glucopyranosyl-β-D-glucopyranoside
- xydammar-24-en-3-yl2-o-beta-d-glucopyranosyl-
- GINSENOOSIDERD
- Ginsenoside Rd (CAS# 52705-93-87)
- GINSENOSIDE Rd hplc
- Ginsenoside Rd std.
- GINSENOSIDE RD WITH HPLC
- (20S)-3β-[[2-O-(β-D-Glucopyranosyl)-β-D-glucopyranosyl]oxy]-20-(β-D-glucopyranosyloxy)dammaran-24-ene-12β-ol
- (20S)-3β-[2-O-(β-D-Glucopyranosyl)-β-D-glucopyranosyloxy]-20-(β-D-glucopyranosyloxy)dammar-24-ene-12β-ol
- [20-(β-D-Glucopyranosyloxy)-12β-hydroxydammar-24-en-3β-yl]2-O-β-D-glucopyranosyl-β-D-glucopyranoside
- 20-(β-D-Glucopyranosyloxy)-12β-hydroxy-5α-dammar-24-ene-3β-yl 2-O-β-D-glucopyranosyl-β-D-glucopyranoside
- 3β-[2-O-(β-D-Glucopyranosyl)-β-D-glucopyranosyloxy]-20-(β-D-glucopyranosyloxy)dammar-24-ene-12β-ol
- ginsenoside--Rd standard
- Ginsenoside Rd ,98%
- Herba Gynostemmatis Pentaphylli
- glucopyranosyloxy)-12-hydroxydammar-24-en-3-yl2-O-β-D-glucopyranosyl-
- β-D-Glucopyranoside,(3β,12β)-20-(β-D-
- Ginsenoside Rd 52705-93-8
- b-D-Glucopyranoside, (3b,12b)-20-(b-D-glucopyranosyloxy)-12-hydroxydammar-24-en-3-yl 2-O-b-D-glucopyranosyl-
- Panaxoside Rd
- Sanchinoside Rd
- β-D-Glucopyranoside, (3β,12β)-20-(β-D-glucopyranosyloxy)-12-hydroxydammar-24-en-3-yl 2-O-β-D-glucopyranosyl-
- ginsenosideR
- 2-O-beta-Glucopyranosyl-(3beta,12beta)-20-beta-D-glucopyranosyloxy-12-hydroxydammar-24-en-3-yl-beta-D-glucopyranoside
- (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
- Chikusetsusaponin FK7
- Gypenoside VIII
- (2S,3R,4S,5S,6R)-2-(((2R,3R,4S,5S,6R)-4,5-Dihydroxy-2-(((3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-((S)-6-methyl-2-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hept-5-en-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
- Rd
Ginsenoside Rd
- Ginsenoside Rd(AS)
- Ginsenoside Rd-RM
- 52705-93-8
- C48H82O19
- Inhibitors
- reference standards from Chinese medicinal herbs (TCM).
- standardized herbal extract
- Ginsenoside series
- chemical reagent
- pharmaceutical intermediate
- phytochemical
- The group of Ginsenosides
- Saponins
